Cargando…
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
Recent years have witnessed major advances that have improved outcome of adults with acute lymphoblastic leukemia (ALL). The emergence of the concept of measurable residual disease has fine-tuned our prognostic models and guided our treatment decisions. The treatment paradigms of ALL have been revol...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275444/ https://www.ncbi.nlm.nih.gov/pubmed/32503572 http://dx.doi.org/10.1186/s13045-020-00905-2 |